Acquired immune deficiency syndrome caused by hyperimmunity

Medical Hypotheses

Volumn 46, Issue 6, 1996, Pages 489-498

  Chigira, M ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CELL DEATH; HUMAN; HYPERIMMUNOGLOBULINEMIA; HYPOTHESIS; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030004331     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90118-8     Document Type: Article

References (139)

1. Lane C H, Masur H, Edger L C, Whalen G, Rook A L, Fauci A S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309: 453-458.
2. Kion T A, Hoffman G W. Anti-HIV and anti-anti-MIC anti-bodies in alloimmune and autoimmune mice. Science 1991; 253: 1138-1140.
3. Muller S, Richalet P, Laurent-Crawford A et al. Auto-antibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients. AIDS 1992; 6: 933-942.
4. Dorsett B, Cronin W, Chuma V, Ioachim HL. Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome. Am J Med 1985; 78: 621-626.
5. + Tcells. Nature 1990; 327: 710-713.
6. Imberti L, Sottiini A, Bettinardi A, Puotti M, Primi D. Selective depletion in HIV-infection of T-cells that bear specific T cell repertoire Vβ sequences. Science 1991; 254: 860-863.
7. Grant M D, Smaili F M, Laurie K, Rosenthal K L. Changes in the cytotoxic T-cell repertoire of HIV-1-infected individuals: relationship to disease progression. Viral Immunol 1993; 6:85-95.
8. Moss P A, Rowland-Jones S L, Frodsham P M et al. Persistent high frequency of human immunodeficiency virusspecific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci (USA) 1995; 92: 5773-5777.
9. Poli G, Fauci A S. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Human Retrovir 1992; 8: 191-197.
10. Ascher M S, Sheppard H W. AIDS as immune system activation: a model for pathogenesis. Clin Exp Immunol 1988; 73: 165-167.
11. Pantaleo G, Graziosi C, Fauci A S. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993; 328: 327-335.
12. Pantaleo G, Fauci A S. New concepts in the immunopathogenesis of HIV infection. Ann Rev Immunol 1995; 13: 487-512.
13. Chigira M, Shinozaki T, Watanabe H. AIDS from an oncological viewpoint: paradoxical immunodeficiency by helper T cell proliferation and senescence. Int J Oncol 1994; 4: 101-107.
14. Seiki M, Inoue J, Takada T, Yoshida M. Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator. EMBO J 1986; 5: 561-565.
15. Gallo R C, Nerurkar L S. Human retroviruses: their role in neoplasia and immunodeficiency. Ann New York Acad Sci 1989; 567: 82-94.
16. Haseltine W A. Molecular biology of the human immunodeficiency virus type 1. FASEB J 1991; 5: 2349-2360.
17. Estaquier J, Idiorek T, Bels F et al. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infection. Proc Natl Acad Sci (USA) 1994; 91: 9431-9435.
18. + T cells from human immunodeficiency virus infected asymptomatic individuals. J Exp Med 1992; 175: 331-340.
19. Ameisen J C, Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 1991; 12: 102-105.
20. Meyaard L, Otto S A, Jonker R R, Mijinster M J, Keet R M, Miedema F. Programmed death of T cells in HIV-1 infection. Science 1992; 257: 217-219.
21. Westendorp M O, Frank R, Ochsenbauer C et al. Sensitization of T cells to CD95-mediated apoptosis by HTV-1 tat and gp120. Nature 1995; 375: 497-500.
22. Copeland K F T, Haaksma A G M, Goudsmit J, Krammer P H, Heeney J L. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I tax. AIDS Res Human Retrovir 1994; 10: 1259-1268.
23. Rieux-Laucat F, Le Deist F, Hivroz C et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347-1349.
24. Roths J B, Murphy E D, Eicher E M. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/ HeJ mice. J Exp Med 1984; 159: 1-20.
25. Cohen P L, Eisenberg R A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol 1991; 9: 243-269.
26. Watanabe-Fukunaga R, Brannan C I, Copeland N G, Jenkins N A, Nagata S. Lymphoproliferation disorder in mice by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
27. Jaleco A C, Covas M J, Victorino R M M. Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patients. Clin Exp Immunol 1994; 98: 185-189.
28. Scadden D T, Zon L I, Groopman J E. Pathophysiology and management of HFV-associated hematologic disorders. Blood 1989; 74: 1455-1463.
29. Balleari E, Timitilli S, Puppo F et al. Impaired in vitro growth of peripheral blood hematopoietic progenitor cells in HIV-infected patients: evidence of an inhibitory effect of autologous T lymphocytes. Ann Hematol 1991; 63: 320-325.
30. Louache F, Henri A, Bettaieb A et al. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992; 80: 2991-2999.
31. Ho D D, Neumann A U, Perelson A S, Chen W, Leopard J M, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-I infection. Nature 1995; 373: 123-126.
32. Wei X, Ghosh S K, Taylor M E et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117-122.
33. Gougeon M L, Collizzi V, Dalgleish A, Montagnier L. New concepts in AIDS pathogenesis. AIDS Res Human Retrovir 1993; 9: 287-289.
34. Michie C, Scott A, Cheesbrough J, Beverley P, Pasvol G. Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effects on T lymphocytes subsets in vivo. Clin Exp Immunol 1994; 98: 140-144.
35. Boyer V, Smith L R, Pezzoli F P, Trauger R J, Jensen F C, Carlo D J. T cell receptor Vβ repertoire in HIV-infected individuals: lack of evidence for selective Vβ deletion. Clin Exp Immunol 1993; 92: 437-441.
36. Chen Z W, Kou Z C, Shen L, Reimann K A, Letvin N L. Conserved T-cell receptor repertoire in simian immunodeficiency virus-infected rhesus monkeys. J Immunol 1993; 151: 2177-2187.
37. β subsets are not preferentially deleted in AIDS. AIDS 1993; 7: 625-631.
38. β expression. Nature 1992; 358: 255-259.
39. Katz D H. AIDS: primary a viral or an autoimmune disease? AIDS Res Hum Retrovir 1993; 9: 489-493.
40. Omenn G S. Familial reticuloendotheliosis with eosinophilia. N Engl J Med 1965; 273:427-432.
41. Filipovich A H, Mathur A, Kamat D, Kersey J H, Shapiro RS. Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency 1994; 5: 91-112.
42. Kuzmich P V, Ecker G A, Karch J. Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases. J Rheumatol 1994; 21: 1649-1654.
43. Kodama M, Kodama T, Kodama M. Is HIV the sole 'sine qua non' cause of AIDS? Int J Oncol 1993; 2: 3-12.
44. Garry R F. New evidence for involvement of retroviruses in Sjögren's syndrome and other autoimmune diseases. Arthr Rheum 1994; 37: 465-469.
45. Kalden J R, Gay S. Retroviruses and autoimmune rheumatic diseases. Clin Exp Immunol 1994; 98: 1-5.
46. Behar S M, Porcelli S A. Mechanisms of autoimmune disease induction. Arthr Rheum 1995; 38: 458-476.
47. Sherman M P, Amin R M, Rodgers-Johnson P E B et al. Identification of human T cell leukemia/lymphoma virus type I antibodies, DNA and protein in patients with polymyositis. Arthr Rheum 1995; 38: 690-698.
48. Grant M D, Weaver M S, Tsoukas C, Hoffman G W. Distribution of antibodies against denatured collagen in AIDS risk group and homosexual AIDS suggests a link between autoimmunity and the immunopathogenesis of AIDS. J Immunol 1990; 144: 1241-1250.
49. Ditzel H J, Barbas S M, Barbas C F, Burton D R. The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection. Proc Natl Acad Sci (USA) 1994; 91: 3710-3714.
50. Cossarizza A, Ortolani C, Mussini C et al. Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J Infect Dis 1995; 172: 105-112.
51. + T cells from HIV-infected subjects. Clin Exp Immunol 1995; 100: 425-433.
52. + cells. J Immunol 1990; 144: 2992-2998.
53. Green J E, Hinrichs S H, Vogel J, Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature 1989; 341: 72-74.
54. Iwakura Y, Tosu M, Yoshida E et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991; 253: 1026-1028.
55. Yamamoto H, Sekiguchi T, Itagaki K, Saijo S, Iwakura Y. Inflammatory polyarthritis in mice transgenic for human T cell leukemia virus type I. Arthr Rheum 1993; 36: 1612-1620.
56. Mariette X, Agbalika F, Daniel M T et al. Detection of human T lymphotropic virus type 1 tax gene in salivary gland epithelium from two patients with Sjögren's syndrome. Arthr Rheum 1993; 36: 1423-1428.
57. Sumida T, Yonaha F, Maeda T et al. Expression of sequences homologous to HTLV-I tax gene in the labial salivary glands of Japanese patients with Sjögren's syndrome. Arthr Rheum 1994; 37: 545-550.
58. Kohler H, Muller S, Nara PL. Deceptive imprinting in the immune response against HIV-1. Immunol Today 1994; 15: 475-478.
59. Veljkovic V, Metlas R, Daniko V et al. Natural autoantibodies cross-react with a peptide derived from the second conserved region of HIV-1 envelope glycoprotein gp120. Biochem Biophys Res Commun 1993; 196: 1019-1024.
60. Blomberg J, Nived O, Pipkorn R, Bengtsson A, Erlinge D, Sturfelt G. Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Arthr Rheum 1994; 37: 57-66.
61. Taniguchi A, Takenaka Y, Noda Y et al. Adult T cell leukemia presenting with proliferative synovitis. Arthr Rheum 1988; 31: 1076-1077.
62. Kitajima I, Murakami I, Murakami Y et al. Polyarthritis in human T lymphotropic virus type I-associated myelopathy. Arthr Rheum 1989; 32: 1342-1344.
63. Nakajima T, Aono H, Hasunuma T et al. Overgrowth of human synovial cells driven by the human T cell leukemia virus type \tax gene. J Clin Invest 1993; 92: 186-193.
64. Scott E J. Anti-cell antibody in macaques. Nature 1991; 353-393.
65. Langlois A J, Weinhold K J, Matthews T J, Greenberg M L, Bolognesi D P. The ability of certain SIV vaccines to provoke reactions against normal cells. Science 1992; 255: 292-293.
66. Gleichmann E, Gleichmann H, Wilke W. Autoimmunization and lymphomagenesis in parent-F1 combinations differing at the major histocompatibility complex model for spontaneous disease caused by altered self-antigen? Transplant Rev 1976; 31: 156-170.
67. Via C S, Sharrow S O, Shearer G M. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J Immunol 1987; 139: 1840-1849.
68. Wirt D P, Brooks E G, Vaidya S, Klimpel G R, Waldmann T A, Goldblum R M. Novel T-lymphocyte population in combined immunodeficiency with features of graft-versus-host disease. N Engl J Med 1989; 321: 370-374.
69. Pollack M S, Kirkpatrick D, Kapoor N, Dupont B, O' Reilly R J. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 1982; 307: 662-666.
70. Shearer G A. A clinical and a scientist look at acquired immunodeficiency syndrome (AIDS): a consequence of allogenic la-antigen recognition. Immunol Today 1983; 4: 181-185.
71. Jouan H, Le Deist F, Nezelof C. Omenn's syndrome: pathologic arguments in favor of a graft-versus-host pathogenesis: a report of nine cases. Human Pathol 1987; 18: 1101-1108.
72. Lake D F, Schluter S F, Wang E, Bernstein R M, Edmundson A B, Marchlonis J J. Autoantibodies to the α/β T-cell receptor in human immunodeficiency virus infection: dysregulation and mimicry. Proc Natl Acad Sci (USA) 1994; 91: 10849-10853.
73. Glazier A, Tutschka P J, Farmer E R, Santos G W. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 1983; 158: 1-8.
74. Hess A D, Horwitz L, Beschorner W E, Santos G W. Development of graft-vs-host disease-like syndrome in cyclosporintreated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-la specificity, including autoreactivity. J Exp Med 1985; 161: 718-730.
75. Hood A F, Vogelsang G B, Black L P, Farmer E R, Santos G W. Acute graft-vs-host disease: development following autologous and syngeneic bone marrow transplantation. Arch Dermatol 1987; 123: 745-750.
76. Vogelsang G B, Hess A D. Graft-versus-host disease: new directions for persistent problem. Blood 1994; 84: 2061-2067.
77. Li C J, Friedman D J, Wang C, Metelev V, Pardee A B. Induction of apoptosis in uninfected lymphocytes by HIV-1 tat protein. Science 1995; 268: 429-431.
78. Grossman W J, Kimata J, Wong F H, Zutter M, Ley T J, Ratner L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci (USA) 1995; 92: 1057-1061.
79. Chigira M. Theoretical basis of paraneoplastic autoimmune syndromes. Oncol Rep 1995; 2: 397-415.
80. Chigira M, Arita S, Watanabe H. Myth of tumor immunology. Int J Oncol 1993; 3: 645-654.
81. Chigira M. A general model of carcinogenesis (I): tumor evolution and gene deletion. Med Hypotheses 1993; 40: 223-226.
82. Chigira M. Selfish cells in altruistic cell society: a theoretical oncology. Int J Oncol 1993; 3: 441-455.
83. Chigira M, Watanabe H. Clonality of malignant tumors. Oncol Rep 1994; 1: 79-81.
84. Chigira M, Arita S, Watanabe H. Loss of heterozygosity: origin or result of carcinogenesis? Int J Oncol 1993; 2: 931-935.
85. Zehender G, Meroni L, Piconi S et al. Frequent detection of antibodies against HTLV antigens in patients with AIDS-related non-Hodgkin lymphoma. AIDS Res Human Retrovir 1995; 11: 823-827.
86. Daniel V, Schimpf K, Opelz G. Lymphocytes autoantibodies and alloantibodies in HIV-1 positive haemophilia patients. Clin Exp Immunol 1989; 75: 178-183.
87. Weimer R, Daniel V, Zimmerman R, Schimpf K, Opelz G. Autoantibodies against CD4 cells are associated with CD4 helper defects in human immunodeficiency virus-infected patients. Blood 1991; 71: 133-140.
88. Boxer L A, Greenberg M S, Boxer G J, Stossel T P. Autoimmune neutropenia. N Engl J Med 1975; 293: 748-753.
89. Cline M J, Opelz G, Saxon A, Fahey J L, Golde D W. Autoimmune panleukopenia. N Engl J Med 1976; 295: 1489-1493.
90. Levitt L J, Ries C A, Greenberg P L. Pure white-cell aplasia: antibody-mediated autoimmune inhibition of granulopoiesis. N Engl J Med 1983; 308: 1141-1146.
91. + hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood 1990; 76: 1281-1286.
92. Lelie J, Lange J M A, Vos J J E, Dalen C M, Danner S A, Borne A E G. Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection. Br J Haematol 1987; 67: 109-114.
93. Bettaieb A, Oksenhendler E, Fromont P, Duedari N, Bierling P. Immunochemical analysis of platelet antibodies in HIV-related thrombocytopenic purpura: a study of 68 patients. Br J Haematol 1989; 73: 241-247.
94. Pedersen N C, Ho E W, Brown M L, Yamamoto J K. Isolation of a T-lymphotropic virus from domestic cats with acquired immune deficiency syndrome. Science 1987; 235: 790-793.
95. Linenberger M L, Beebe A M, Pedersen N C, Abkowitz J L, Dandekar S. Marrow accessory cell infection and alterations in hematopoiesis accompany severe neutropenia during experimental acute infection with feline immunodeficiency virus. Blood 1995; 85: 941-951.
96. Chigira M. Self and not self: duality of immunity. Med Hypotheses 1994; 43: 6-10.
97. Jerne N K. The immune system. Sci Am 1973; 229: 52-60.
98. Jerne N K. Towards a network theory of the immune system. Ann Immunol Paris 1975; 125C: 373-389.
99. Hoffman G W, Kion T A, Grant M D. An idiotypic network model of AIDS immunopathogenesis. Proc Natl Acad Sci (USA) 1991; 88: 3060-3064.
100. Kaczmarski W, Khan S A. Lupus autoantigen Ku protein binds HIV-1 tar RNA in vitro. Biochem Biophys Res Commun 1993; 196: 935-942.
101. Bost K L, Hahn M B H, Saaz M S, Shaw G M, Weigent D A, Blalock J E. Individuals infected with HIV possess antibodies against IL-2. Immunol 1988; 465: 611-615.
102. + lymphocyte response in acutely infected rhesus monkeys. J Virol 1993; 67: 1707-1711.
103. Safrit J T, Lee A Y, Andrews C A, Koup R A. A region of third variable loop of HIV-1 gp120 is recognized by HLA-B27-restricted CTLs from two acute seroconversion patients. J Immunol 1994; 153: 3822-3830.
104. β repertoire in an acute infection of Rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus. J Exp Med 1995; 182: 21-31.
105. Vaz N M, Varela F J. Self and non-sense: an organism-centered approach to immunology. Med Hypotheses 1978; 4: 231-267.
106. Chigira M, Watanabe H. Differentiation as symbiosis. Med Hypotheses 1994; 43: 17-18.
107. Clerici M, Shearer G M. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15: 575-581.
108. Nowak M A, May R M, Phillips R E et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 1995; 375: 606-611.
109. Maruyama M. The second cybernetics: deviation-amplifying mutual causal processes. Am Scientist 1963; 51: 164-179.
110. Marsh J, Socie G, Shrezenmeier H et al. Hemopoietic growth factors in aplastic anemia: a cautionary note. Lancet 1994; 344: 172-173.
111. Borkowsky W, Krasinski K, Moore T, Papaevangelou V. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children. AIDS Res Human Retrovir 1990; 6: 673-678.
112. Daar E S, Moudgil T, Meyer R D, Ho D D. Transient high levels of viremia in patients with primary human immuno-deficiency virus type I infection. N Engl J Med 1991; 324: 961-964.
113. Corey L. Reducing T cell activation as a therapy for human immunodeficiency virus infection. J Infect Dis 1995; 171: 521-522.
114. Karpas A, Lowdell M, Jacobson S K, Hill F. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. Proc Natl Acad Sci (USA) 1992; 89: 8351-8355.
115. Bell K D, Ramilo O, Vitetta E S. Combined use of an immunotoxin and cyclosporin to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus. Proc Natl Acad Sci (USA) 1993; 90: 1411-1415.
116. Sigal N H, Dumont F J. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Ann Rev Immunol 1992; 10: 519-560.
117. Franke E K, Yuan H E H, Luban J. Specific incorporation of cyclosporin A into HTV-1 virions. Nature 1994; 372: 359-362.
118. Thali M, Bukovsky A, Kondo E et al. Functional association of cyclosporin A with HIV-1 virions. Nature 1994; 372: 363-365.
119. Weber J, Galpin S. Cyclosporin A: in HIV results in the frame. Nature 1995; 375: 198.
120. Yazdabbajhash K, Choi J W, Li Y, Lau L F, Choi Y. Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77. Proc Natl Acad Sci (USA) 1995; 92: 437-441.
121. Andrieu J M, Lu W, Levy R. Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. J Infect Dis 1995; 171: 523-527.
122. Jolicoeur P. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. FASEB J 1991; 5: 2398-2405.
123. Bartz S R, Hohenwalter E, Hu M K, Rich D H, Malkovsky M. Inhibition of human immunodecificiency virus replication by nonimmunosuppressive analogs of cyclosporin A. Proc Natl Acad Sci (USA) 1995; 92: 5381-5385.
124. Leonard E M, Raefsky E, Griffith P, Kimball J, Nienhuis A W, Yound N S. Cyclosporin therapy of aplastic anemia, congenital and acquired red cell aplasia. Br J Haematol 1989; 72: 278-284.
125. Camitta B M, Doney K. Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results. Am J Pediatr Hematol Oncol 1990; 12: 411-424.
126. Rosenfeld S J, Kimball J, Vining D, Young N S. Intensive immunosuppression wilh antithymocyte globulin and cyclosporin as treatment for severe acquired aplastic anemia. Blood 1995; 85: 3058-3065.
127. Schiphorst P P, Pauw B E. Autoimmune neutropenia successfully treated with cyclosporin. Ann Hematol 1995; 70: 223-225.
128. Kunicki T J, Newman P J. The molecular immunology of human platelet proteins. Blood 1992; 80: 1386-1404.
129. Bussel J B, Pham L C, Aledort L, Nachman R. Maintenance treatment of adult with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobin. Blood 1988; 72: 121-127.
130. Reiner A, Gersheimer T, Slichter S J. Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura. Blood 1995; 85: 351-358.
131. Champlin R, Ho W, Gale R P. Antithymocytes globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med 1983; 308: 113-118.
132. Planque M M, Bacigalupo A, Wursch A et al. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Br J Haematol 1989; 73: 121-126.
133. Frickhofen N, Kaltwasser F, Schrezenmeier H et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporin. N Engl J Med 1991; 324: 1297-1304.
134. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol 1988; 69: 413-418.
135. Moiser D E, Gulizia R J, Baird S M, Wilson D B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256-259.
136. Duchosal M A, Eming S A, McConahey P J, Dixson F J. The hu-PBL-SCID mouse model: long-term serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice. Cell Immunol 1992; 139: 468-477.
137. Vittecoq V, Chevret S, Morand-Joubert L et al. Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs transfusions of seronegative plasma. Proc Natl Acad Sci (USA) 1995; 92: 1195-1199.
138. Storb R. Bone marrow transplantation for aplastic anemia. Cell Transplant 1993; 2: 365-379.
139. Bryson Y J, Pang S, Wei L S, Dickover R, Diagne A, Chen I S Y. Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995; 332: 833-838.